Transcatheter aortic valve replacement (TAVR) in bicuspid anatomy provides outcomes roughly similar to those with tricuspid aortic stenosis among patients at low surgical risk, a large national ...
Operators continue to disagree on the necessity of conducting a randomized controlled trial of transcatheter aortic valve replacement (TAVR) in people with bicuspid anatomy, a prominent group that had ...
Transcatheter aortic valve replacement (TAVR) provides comparable stroke and mortality rates out to 1 year in low-risk patients with bicuspid and tricuspid aortic stenosis, registry data suggest.
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window With proper ...
Revised Commercial Labeling Broadens Patient Population Who May be Candidates for Transcatheter Aortic Valve Replacement (TAVR) DUBLIN, Aug. 21, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the ...
Advocate Health Care heart patient Diana Esposito was recognized as the Chicago Bears’ special guest during the Bear Down ...
ACC.20/WCC: Low Rates of Paravalvular Leak and High Survival Observed in Late-breaking Clinical Trial of Low-Risk Bicuspid Aortic Stenosis Patients DUBLIN, March 29, 2020 (GLOBE NEWSWIRE) -- Medtronic ...
Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below: Receive the the latest news, research, and presentations from major meetings ...
Please provide your email address to receive an email when new articles are posted on . Raj R. Makkar, MD, vice president of cardiovascular innovation and intervention and the Stephen R. Corday, MD, ...
Please provide your email address to receive an email when new articles are posted on . At 5 years, there was no difference in death or disabling stroke between transcatheter aortic valve replacement ...
Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below: Receive the the latest news, research, and presentations from major meetings ...
IRVINE, Calif., May 18, 2021 /PRNewswire/ -- Edwards Lifesciences (NYSE: EW) today announced the results of a real-world study comparing outcomes for patients with bicuspid aortic stenosis (AS) who ...